Insider Transactions in Q2 2021 at Vera Therapeutics, Inc. (VERA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2021
|
Andrew Cheng |
BUY
Conversion of derivative security
|
Indirect |
17,488
+50.0%
|
-
|
|
May 18
2021
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|
|
May 18
2021
|
Patrick G Enright |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Beth C Seidenberg |
BUY
Conversion of derivative security
|
Indirect |
1,343,152
+34.66%
|
-
|
|
May 18
2021
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Maha Katabi |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
909,090
+22.7%
|
$9,999,990
$11.0 P/Share
|
|
May 18
2021
|
Longitude Capital Partners Iv, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
727,272
+19.97%
|
$7,999,992
$11.0 P/Share
|
|
May 18
2021
|
Sofinnova Venture Partners X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Kurt Von Emster Director |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
772,727
+20.7%
|
$8,499,997
$11.0 P/Share
|
|
May 18
2021
|
Abingworth LLP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,187,504
+50.0%
|
-
|
|
May 17
2021
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Direct |
17,828
+50.0%
|
$213,936
$12.04 P/Share
|